Red: Unlike you, I don't think Q4 went off very well for us. I think all of us including Gerald expected the Retinitis Orphan announcement and the Lympro launch to do more for the stock price than they did....which was nothing! I was giving my opinion as to why the stock price didn't move any, even with great news. I feel the low ball Lympro revenue estimate given by Jason and not responded to by Gerald made a lot of shareholders scratch their heads. This is a message board where we all speculate. Maybe you think December went splendidly and you have every right to your opinion. But describing me as being "wound up" over the issue sounds condescending. No need for that. Strong well expressed arguments, which you often give, are what's needed on the message board.